bluebird bio, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Option Exercise | A | 28.44 | 25,000 | 711,000 | 25,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Sell | S | 28.16 | 693 | 19,516 | 35,529 | 36.2 K to 35.5 K (-1.91 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 2,141 | 0 | 36,222 | 34.1 K to 36.2 K (+6.28 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 12,500 | 0 | 34,081 | 21.6 K to 34.1 K (+57.92 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Burnett Katy | Principal Accountin ... | Sell | S | 28.16 | 518 | 14,588 | 4,097 | 4.6 K to 4.1 K (-11.22 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Burnett Katy | Principal Accountin ... | Grant | A | 0.00 | 1,427 | 0 | 4,615 | 3.2 K to 4.6 K (+44.76 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Burnett Katy | Principal Accountin ... | Grant | A | 0.00 | 2,000 | 0 | 3,188 | 1.2 K to 3.2 K (+168.35 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | A | 28.44 | 25,000 | 711,000 | 25,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 28.16 | 664 | 18,699 | 46,946 | 47.6 K to 46.9 K (-1.39 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Grant | A | 0.00 | 2,162 | 0 | 47,610 | 45.4 K to 47.6 K (+4.76 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Grant | A | 0.00 | 12,500 | 0 | 45,448 | 32.9 K to 45.4 K (+37.94 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Option Exercise | A | 28.44 | 30,000 | 853,200 | 30,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 28.16 | 749 | 21,093 | 40,200 | 40.9 K to 40.2 K (-1.83 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Grant | A | 0.00 | 2,065 | 0 | 40,949 | 38.9 K to 40.9 K (+5.31 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Grant | A | 0.00 | 15,000 | 0 | 38,884 | 23.9 K to 38.9 K (+62.80 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | A | 28.44 | 20,000 | 568,800 | 20,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 28.16 | 698 | 19,657 | 47,871 | 48.6 K to 47.9 K (-1.44 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 2,271 | 0 | 48,569 | 46.3 K to 48.6 K (+4.91 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 46,298 | 36.3 K to 46.3 K (+27.55 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Option Exercise | A | 28.44 | 27,500 | 782,100 | 27,500 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 28.16 | 665 | 18,727 | 48,035 | 48.7 K to 48 K (-1.37 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Grant | A | 0.00 | 2,165 | 0 | 48,700 | 46.5 K to 48.7 K (+4.65 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Grant | A | 0.00 | 13,750 | 0 | 46,535 | 32.8 K to 46.5 K (+41.94 %) |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | A | 28.44 | 90,000 | 2,559,600 | 90,000 | |
| Feb 18 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Grant | A | 0.00 | 18,000 | 0 | 104,669 | 86.7 K to 104.7 K (+20.77 %) |
| Feb 17 2021 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Sell | S | 45.52 | 1,216 | 55,352 | 21,581 | 22.8 K to 21.6 K (-5.33 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Obenshain Andrew | President of SGD | Sell | S | 45.93 | 34 | 1,561 | 23,884 | 23.9 K to 23.9 K (-0.14 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 45.93 | 63 | 2,893 | 36,298 | 36.4 K to 36.3 K (-0.17 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 45.93 | 594 | 27,280 | 86,669 | 87.3 K to 86.7 K (-0.68 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 45.93 | 38 | 1,745 | 32,785 | 32.8 K to 32.8 K (-0.12 %) |
| Feb 04 2021 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 45.93 | 59 | 2,710 | 32,948 | 33 K to 32.9 K (-0.18 %) |